121 related articles for article (PubMed ID: 16966296)
1. Small cell variant of T-cell prolymphocytic leukemia exhibiting suppressor phenotype.
Thorat KB; Gujral S; Kumar A; Nair CN
Leuk Lymphoma; 2006 Aug; 47(8):1711-3. PubMed ID: 16966296
[No Abstract] [Full Text] [Related]
2. Unusual lymphoma manifestations: case 3. CD8+ T-cell prolymphocytic leukemia.
Nakajima H; Oki M; Ando K
J Clin Oncol; 2004 Feb; 22(3):560-2. PubMed ID: 14752080
[No Abstract] [Full Text] [Related]
3. Are activation markers (CD25, CD38 and CD103) predictive of sensitivity to purine analogues in patients with T-cell prolymphocytic leukemia and other lymphoproliferative disorders?
Delgado J; Bustos JG; Jimenez MC; Quevedo E; Hernandez-Navarro F
Leuk Lymphoma; 2002 Dec; 43(12):2331-4. PubMed ID: 12613520
[TBL] [Abstract][Full Text] [Related]
4. [Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Valiev TT; Vinogradova IuE; Chernova NG; Mar'in DS; Volkova IaK; Petrova VI; Bulanov AIu; Kalinin NN; Semenova EA; Gretsov EM; Kravchenko SK; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2006; 78(7):87-90. PubMed ID: 16944758
[No Abstract] [Full Text] [Related]
5. Conjunctival involvement with T-cell prolymphocytic leukemia: report of a case and review of the literature.
Lee SS; Robinson MR; Morris JC; Mirtsching BC; Shen D; Chan CC
Surv Ophthalmol; 2004; 49(5):525-36. PubMed ID: 15325197
[TBL] [Abstract][Full Text] [Related]
6. Seropositive polyarthritis and skin manifestations in T-prolymphocytic leukemia/Sezary cell leukemia variant.
Dybjer A; Hellquist L; Johansson B; Rydgren L; Billström R
Leuk Lymphoma; 2000 Apr; 37(3-4):437-40. PubMed ID: 10752996
[TBL] [Abstract][Full Text] [Related]
7. A brief intensive chemotherapy in T-prolymphocytic leukemia.
Billio A; Pescosta N; Rosanelli C; Fabris P; Coser P
Haematologica; 2000 Apr; 85(4):438-9. PubMed ID: 10756378
[No Abstract] [Full Text] [Related]
8. [Prolymphocytic leukemia].
Jantunen E; Lahtinen R
Duodecim; 1992; 108(10):955-9. PubMed ID: 1366274
[No Abstract] [Full Text] [Related]
9. Small cell variant of T-cell prolymphocytic leukemia with a gammadelta immunophenotype.
Toyota S; Nakamura N; Dan K
Int J Hematol; 2005 Jan; 81(1):66-8. PubMed ID: 15717692
[TBL] [Abstract][Full Text] [Related]
10. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
[TBL] [Abstract][Full Text] [Related]
11. T-cell prolymphocytic leukemia with hemorrhagic gastrointestinal involvement and a new chromosomal abnormality.
Toyota S; Nakamura N; Dan K
Int J Hematol; 2002 Apr; 75(3):314-7. PubMed ID: 11999363
[TBL] [Abstract][Full Text] [Related]
12. Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
Witzig TE; Weitz JJ; Lundberg JH; Tefferi A
Leuk Lymphoma; 1994 Jun; 14(1-2):137-9. PubMed ID: 7920220
[TBL] [Abstract][Full Text] [Related]
13. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
[TBL] [Abstract][Full Text] [Related]
14. Chlorambucil and prednisolone therapy in a patient with T-cell chronic lymphocytic leukaemia.
Islam A; Majer R; Cumber P; Poynton C
Clin Lab Haematol; 1996 Jun; 18(2):125-6. PubMed ID: 8866149
[No Abstract] [Full Text] [Related]
15. Complete remission in T-cell prolymphocytic leukemia with 2-chlorodeoxyadenosine.
Palomera L; Domingo JM; Agulló JA; Soledad Romero M
J Clin Oncol; 1995 May; 13(5):1284-5. PubMed ID: 7738636
[No Abstract] [Full Text] [Related]
16. [Cutaneous manifestations of T-cell prolymphocytic leukemia].
De Belilovsky C; Guillaume JC; Gilles E; Bosq J; Hayat M; Desvignes V; Avril MF
Ann Dermatol Venereol; 1989; 116(11):889-91. PubMed ID: 2619197
[No Abstract] [Full Text] [Related]
17. Helper-suppressor T-cell leukemia: unusual phenotype controlled with low-dose deoxycoformycin.
Adler MJ; Hershberg R; Yu A
Am J Hematol; 1991 Mar; 36(3):208-10. PubMed ID: 1825447
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous involvement as the first manifestation in a case of T-cell prolymphocytic leukaemia.
Serra A; Estrach MT; Martí R; Villamor N; Rafel M; Montserrat E
Acta Derm Venereol; 1998 May; 78(3):198-200. PubMed ID: 9602226
[TBL] [Abstract][Full Text] [Related]
19. Involvement of central nervous system in prolymphocytoid transformation of chronic lymphocytic leukemia.
Kuwabara H; Kanamori H; Takasaki H; Takabayashi M; Yamaji S; Tomita N; Fujimaki K; Fujisawa S; Ishigatsubo Y
Leuk Lymphoma; 2003 Jul; 44(7):1235-7. PubMed ID: 12916878
[TBL] [Abstract][Full Text] [Related]
20. Perforin-positive leukemic cell infiltration in the aortic tissue of a patient with T-cell prolymphocytic leukemia.
Seko Y; Azuma M; Yagita H; Okumura K; Yazaki Y
Int Angiol; 1996 Sep; 15(3):245-8. PubMed ID: 8971584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
